SCHEMBL21644543

SCHEMBL21644543

CCN(C(=O)c1cc(C(C)C)c(O)cc1O)c1ncnc2c1ccn2C

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
MET P08581 1/20 0.50
CYP2B6 P20813 1/20 0.50
HSP90AA1 P07900 15/20 0.41
NOTUM Q6P988 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP3A5 P20815 1/20 0.37
CYP3A7 P24462 1/20 0.37
CYP3A43 Q9HB55 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21644623 0.92 MET (0.44) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21644628 0.87 HSP90AA1 (0.42) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21678120 0.86 HSP90AA1 (0.39) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL30019603 0.86 HSP90AA1 (0.39) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21644569 0.78 MET (0.68) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21644719 0.75 ABL1 (0.39) CYP3A4HSP90AA1NOTUMHDAC3HDAC1
SCHEMBL21644695 0.72 CYP3A4 (0.55) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21644562 0.72 MET (0.58) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL30779548 0.72 CYP3A4 (0.55) CYP3A4CYP2C9CYP2C19METCYP2B6
SCHEMBL21644626 0.71 MET (0.57) CYP3A4CYP2C9CYP2C19METCYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111164074-B Heat shock protein 90 inhibitors 台北医学大学 2024-02-02 CN disclosed
US-11479528-B2 Heat shock protein 90 inhibitors TAIPEI MEDICAL UNIVERSITY (TW) 2022-10-25 US disclosed
US-20200039923-A1 HEAT SHOCK PROTEIN 90 INHIBITORS TAIPEI MEDICAL UNIVERSITY (TW) 2020-02-06 US disclosed
US-20200039923-A1 HEAT SHOCK PROTEIN 90 INHIBITORS TAIPEI MEDICAL UNIVERSITY (TW) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200039923-A1 HEAT SHOCK PROTEIN 90 INHIBITORS HSP90AB1, HSP90AB2P, HSP90AA1 CYP3A4 4066/4885CYP2C9 4003/4885CYP2C19 4107/4885
US-11479528-B2 Heat shock protein 90 inhibitors HSP90AB1, HSP90AB2P, HSP90AA1 CYP3A4 4066/4885CYP2C9 4003/4885CYP2C19 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.